David Nathanson

731 total citations
22 papers, 500 citations indexed

About

David Nathanson is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, David Nathanson has authored 22 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in David Nathanson's work include Electrolyte and hormonal disorders (8 papers), Diabetes Management and Research (5 papers) and Diabetes Treatment and Management (4 papers). David Nathanson is often cited by papers focused on Electrolyte and hormonal disorders (8 papers), Diabetes Management and Research (5 papers) and Diabetes Treatment and Management (4 papers). David Nathanson collaborates with scholars based in Sweden, United Kingdom and United States. David Nathanson's co-authors include Henrik Falhammar, Jan Calissendorff, Buster Mannheimer, Jakob Skov, Jonatan D. Lindh, Thomas Nyström, Anna Norhammar, Johan Bodegård, Jan W. Eriksson and Marcus Thuresson and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

David Nathanson

20 papers receiving 494 citations

Peers

David Nathanson

EDM

PRM

PMH

SURGE

Yao Neng Teo Singapore

Caner Karahan Türkiye

Xingyao Tang China

Valéria Costa‐Hong Brazil

Christopher O. Leonards Germany

Jerzy Loba Poland

Almira Babovic Norway

Faruk Kılınç Türkiye

Elisenda Gómez-Angelats Spain

Larisa Kovačević United States

Yao Neng Teo Singapore

David Nathanson

250 ×1.2

EDM

98 ×0.5

PRM

86 ×0.9

59 ×0.7

PMH

142 ×1.8

SURGE

Citations per year, relative to David Nathanson David Nathanson (= 1×) peers Yao Neng Teo

Countries citing papers authored by David Nathanson

Since Specialization

Citations

This map shows the geographic impact of David Nathanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Nathanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Nathanson more than expected).

Fields of papers citing papers by David Nathanson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Nathanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Nathanson. The network helps show where David Nathanson may publish in the future.

Co-authorship network of co-authors of David Nathanson

This figure shows the co-authorship network connecting the top 25 collaborators of David Nathanson. A scholar is included among the top collaborators of David Nathanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Nathanson. David Nathanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eeg‐Olofsson, Katarina, David Nathanson, Tim Spelman, et al.. (2025). Severe hypoglycaemia is associated with increased risk of adverse cardiovascular complications in adults with type 1 diabetes: risk mitigation using intermittently scanned continuous glucose monitoring. Diabetologia. 68(8). 1647–1656.

Nathanson, David, Katarina Eeg‐Olofsson, Tim Spelman, et al.. (2024). Intermittently scanned continuous glucose monitoring compared with blood glucose monitoring is associated with lower HbA1c and a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies. Diabetologia. 68(1). 41–51. 5 indexed citations

Eeg‐Olofsson, Katarina, David Nathanson, Tim Spelman, et al.. (2024). Initiation of Intermittently Scanned Continuous Glucose Monitoring Is Associated With Reduced Hospitalization for Acute Diabetes Events and Cardiovascular Complications in Adults With Type 1 Diabetes. Diabetes Care. 47(12). 2164–2171. 4 indexed citations

Hamilton, Kathryn, Rita Forde, Mette Due‐Christensen, et al.. (2023). Which diabetes specific patient reported outcomes should be measured in routine care? A systematic review to inform a core outcome set for adults with Type 1 and 2 diabetes mellitus: The European Health Outcomes Observatory (H2O) programme. Patient Education and Counseling. 116. 107933–107933. 7 indexed citations

Falhammar, Henrik, Ove Törring, Martin Larsson, & David Nathanson. (2022). Hypoglycemia after exposure of diclofenac medication. Endocrine. 79(3). 455–458. 1 indexed citations

Brinck, Jonas, Emil Hagström, Stefan Franzén, et al.. (2022). Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study. Diabetes Care. 45(12). 3040–3049. 6 indexed citations

Nathanson, David, Ann‐Marie Svensson, Mervete Miftaraj, et al.. (2021). Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls. Diabetologia. 64(7). 1595–1603. 36 indexed citations

Falhammar, Henrik, Jakob Skov, Jan Calissendorff, et al.. (2020). Associations Between Antihypertensive Medications and Severe Hyponatremia: A Swedish Population–Based Case–Control Study. The Journal of Clinical Endocrinology & Metabolism. 105(10). e3696–e3705. 23 indexed citations

Mannheimer, Buster, Jakob Skov, Henrik Falhammar, et al.. (2019). Sex-specific risks of death in patients hospitalized for hyponatremia: a population-based study. Endocrine. 66(3). 660–665. 14 indexed citations

10.

Falhammar, Henrik, Jan Calissendorff, Jakob Skov, et al.. (2019). Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study. European Journal of Internal Medicine. 69. 20–24. 23 indexed citations

11.

Toivanen, Susanna, Kristina Johnell, Jan Calissendorff, et al.. (2019). Factors of importance for discontinuation of thiazides associated with hyponatremia in Sweden: A population‐based register study. Pharmacoepidemiology and Drug Safety. 29(1). 77–83. 4 indexed citations

12.

Falhammar, Henrik, Jonatan D. Lindh, Jan Calissendorff, et al.. (2018). Antipsychotics and severe hyponatremia: A Swedish population–based case–control study. European Journal of Internal Medicine. 60. 71–77. 32 indexed citations

13.

Falhammar, Henrik, Jonatan D. Lindh, Jan Calissendorff, et al.. (2018). Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population–based case–control study. Seizure. 59. 28–33. 35 indexed citations

14.

Falhammar, Henrik, Jonatan D. Lindh, Jan Calissendorff, et al.. (2018). Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population–based case–control study. European Journal of Internal Medicine. 59. 65–69. 37 indexed citations

15.

Lindh, Jonatan D., Jan Calissendorff, Jakob Skov, et al.. (2017). Differences in Associations of Antidepressants and Hospitalization Due to Hyponatremia. The American Journal of Medicine. 131(1). 56–63. 49 indexed citations

16.

Kostulas, Nikolaos, Martin Larsson, Tor-Björn Käll, Mia von Euler, & David Nathanson. (2017). Safety of thrombolysis in stroke mimics: an observational cohort study from an urban teaching hospital in Sweden. BMJ Open. 7(10). e016311–e016311. 19 indexed citations

17.

Norhammar, Anna, Johan Bodegård, Thomas Nyström, et al.. (2016). Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013. Diabetologia. 59(8). 1692–1701. 97 indexed citations

18.

Larsson, Martin, Grażyna Lietzau, David Nathanson, et al.. (2016). Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4. Bioscience Reports. 36(6). 23 indexed citations

19.

Nathanson, David, Cesare Patrone, Thomas Nyström, & Mia von Euler. (2014). Sex, Diastolic Blood Pressure, and Outcome after Thrombolysis for Ischemic Stroke. Stroke Research and Treatment. 2014. 1–7. 8 indexed citations

20.

Darsalia, Vladimer, Martin Larsson, Carina Mallard, et al.. (2014). Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization. PLoS ONE. 9(8). e103114–e103114. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact